Table 3 Results of subgroup analyses
| Â | DOR (95% CI) | AUC (95% CI) | Sensitivity (95% CI) | Specificity (95% CI) | Likelihood ratio (95% CI) | |
|---|---|---|---|---|---|---|
Positive | Negative | |||||
Patients with HM and HSCT/SOT | 33 (16–69) | 0.89 (0.86–0.92) | 0.68 (0.58–0.76) | 0.94 (0.89–0.97) | 11.3 (6.3–20.3) | 0.34 (0.25–0.45) |
Patients with COPD, solid tumor, prolonged use of corticosteroids, etc | 88 (33–237) | 0.96 (0.94–0.97) | 0.88 (0.75–0.95) | 0.92 (0.83–0.96) | 11.0 (5.4–22.7) | 0.13 (0.05–0.29) |